Sympathetic nervous system (SNS) regulation of cardiac action potential duration (APD) is mediated by ␤ adrenergic receptor (␤AR) activation, which increases the slow outward potassium ion current (I KS ). Mutations in two human I KS channel subunits, hKCNQ1 and hKCNE1, prolong APD and cause inherited cardiac arrhythmias known as LQTS (long QT syndrome). We show that ␤AR modulation of I KS requires targeting of adenosine 3Ј,5Ј-monophosphate (cAMP)-dependent protein kinase (PKA) and protein phosphatase 1 (PP1) to hKCNQ1 through the targeting protein yotiao. Yotiao binds to hKCNQ1 by a leucine zipper motif, which is disrupted by an LQTS mutation (hKCNQ1-G589D). Identification of the hKCNQ1 macromolecular complex provides a mechanism for SNS modulation of cardiac APD through I KS .
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Cardiac function is regulated by the SNS; stimulation of ␤ARs increases heart rate and contractility and shortens APD (1) . ␤AR-mediated regulation of I KS is particularly important because patients with KCNQ1 or KCNE1 mutations have a form of LQTS (2, 3) in which fatal cardiac arrhythmias are precipitated by increased SNS activity associated with exercise and startling (4 -6) .
Because ␤AR signaling results in PKA activation, we sought to determine whether PKA and a phosphatase were components of an hKCNQ1 macromolecular signaling complex. In immunoprecipitations of hKCNQ1 from cardiac homogenates, we found that PKA catalytic and regulatory (RII) subunits, protein phosphatase 1 (PP1) (but not PP2A), and the PKA-and PP1-targeting protein yotiao [which also targets PKA and PP1 to N-methyl-D-aspartate (NMDA) receptors in the brain (7)] coimmunoprecipitated with hKCNQ1 from human cardiac homogenates (Fig. 1A) . Thus, the PKA catalytic and regulatory subunits, PP1, and yotiao are components of the hKCNQ1 macromolecular complex.
Microcystin Sepharose beads (which bind to PP1) and cAMP Sepharose beads (which bind to the PKA regulatory subunit) specifically associated with hKCNQ1 when incubated with cardiac homogenates from a transgenic mouse ( TG ϩ ) expressing an hKCNQ1-hKCNE1 fusion protein in the heart. No such association was detected in homogenates from wild-type ( WT ) mouse hearts, which lack I KS because their heart rate (ϳ500 beats per minute) requires K ϩ channels with faster kinetics to control APD (Fig. 1B) . PKA catalytic and regulatory (RII) subunits, PP1, and yotiao were also associated with hKCNQ1-hKCNE1 from TG ϩ mouse hearts (Fig. 1C) . The binding of kinases and phosphatases to ion channels through targeting proteins can be mediated by leucine zipper (LZ ) motifs (8) . We tested whether a LZ motif in the COOH-terminus of hKCNQ1 (amino acid residues 588 to 616) functioned in targeting PKA and PP1 to hKCNQ1 through yotiao. Glutathione Stransferase (GST)-KCNQ1 fusion proteins were incubated with cardiac muscle Fig. 1 . Presence of PKA, RII, PP1, and the targeting protein yotiao in the KCNQ1 macromolecular complex. (A) KCNQ1 immunoprecipitated from human cardiac homogenates using anti-KCNQ1 (22). Positive control for immunoblotting was human cardiac homogenate; negative control for immunoprecipitation was anti-KCNQ1 preabsorbed with the antigenic peptide (lane 3). (B) For pull-down assays, either microcystin-or cAMPSepharose beads were incubated with cardiac homogenates from wild-type (WT) or TG ϩ mice (expressing hKCNQ1-hKCNE1) (23). Bound proteins were immunoblotted with antihKCNQ1. Specificity of the microcystin pull-down was demonstrated using free microcystin LR. "ϩcontrol" is anti-hKCNQ1 immunoblot of TG ϩ cardiac homogenate that recognizes the hKCNQ1-hKCNE1 fusion product of the transgene, which migrates at ϳ125 kD. (C) Proteins were immunoprecipitated from homogenates of WT or hKCNQ1-hKCNE1 TG ϩ mouse hearts with anti-hKCNQ1 and immunoblotted with anti-hKCNQ1, anti-PKA (catalytic subunit), anti-RII (PKA regulatory subunit), anti-PP1 (catalytic subunit of PP1), and anti-yotiao. "ϩ control" is TG ϩ cardiac homogenate. (D) Proteins from cardiac homogenates (200 g) that associated with GST-hKCNQ1 fusion proteins (24) were immunoblotted with anti-yotiao, anti-PKA, and anti-PP1 (25). "ϩ control" is TG ϩ cardiac homogenate. Data shown are representative of three or more experiments.
homogenates from human or TG ϩ (hKCNQ1-hKCNE1) mouse hearts. GST-KCNQ1-LZ, containing the LZ motif, coprecipitated PP1, PKA, and yotiao (Fig. 1D ). This interaction was specific, as neither GST alone nor GST-KCNQ1 fragments from other intracellular regions without the LZ motif coprecipitated PP1, PKA, or yotiao (Fig. 1D) . GST-KCNQ1-LZ did not directly bind recombinant PP1 or PKA catalytic subunits (9), indicating that the binding of PP1 and PKA to hKCNQ1 requires yotiao. Moreover, a mutant peptide (KCNQ1-LZ m ) containing alanine substitutions (Leu 602 3 Ala, Ile 609 3 Ala) that disrupt the LZ motif did not coprecipitate PP1, PKA, or yotiao. Yotiao contains multiple coiled coils that can form LZs but has not been reported to bind to targets via LZs. Kinase and phosphatase binding to ion channels through specific targeting proteins provides a mechanism regulating phosphorylation at the subcellular level (10, 11) . For example, PP1 is targeted to the type 2 ryanodine receptor-calcium release channel on the cardiac sarcoplasmic reticulum through spinophilin (8) and is now shown to interact through yotiao with hKCNQ1 in the plasma membrane.
Addition of cAMP, in the absence of exogenous PKA, induced phosphorylation of immunoprecipitated KCNQ1 ( Fig. 2A) . Using an alanine substitution, we identified Ser 27 as the unique site of PKA phosphorylation on hKCNQ1 (Fig. 2B) . We did not detect AKAP 79 or AKAP 15-18 (other PKA targeting proteins) with KCNQ1. Indeed, our data show that yotiao is the only protein that targets PKA and PP1 to hKCNQ1 complex, because incubation of cardiac homogenates with a peptide containing the KCNQ1 LZ motif (which binds yotiao) prevented coimmunoprecipitation of yotiao, PKA, and PP1 with KCNQ1 (Fig. 2C) . The corresponding mutant peptide containing a disrupted LZ (GST-KCNQ1-LZ m ) did not disrupt complexes of KCNQ1 with yotiao, PKA, or PP1 (Fig. 2C) .
When hKCNQ1 and yotiao were coexpressed in Chinese hamster ovary (CHO) cells, PKA and PP1 were coimmunoprecipitated with hKCNQ1 (Fig. 2D) . Without yotiao, PKA and PP1 did not coimmunoprecipitate with hKCNQ1 (Fig. 2D) . Disrupting the hKCNQ1 LZ with alanine substitutions (KCNQ1-LZ m ) or with the LQTS-associated KCNQ1-G589D mutation (Gly 589 is the first "e" position in the COOH-terminal hKCNQ1 LZ motif ) prevented binding of yotiao, PKA, or PP1 to the channel (Fig. 2D) . Thus, the LZ motif is required for yotiao-mediated targeting of PKA and PP1 to hKCNQ1.
The membrane-permeant cAMP analog 8 Br-cAMP (300 M) significantly increased hKCNQ1-hKCNE1 tail currents after ϩ60 mV prepulses 1.8 Ϯ 0.1-fold (n ϭ 9) (Fig.  3A) in myocytes from mice expressing the human proteins. cAMP has similar effects on native I KS recorded from guinea pig ventricular myocytes (12) . hKCNQ1-hKCNE1 channel activity (assayed from tail currents after ϩ60 mV prepulses) was significantly enhanced (3.6 Ϯ 0.7 fold, n ϭ 5) (Fig. 3A) by cAMP (300 M) plus okadaic acid (OA, 1 M), a PP1 inhibitor that binds to the phosphatase catalytic site. OA alone did not significantly increase hKCNQ1-hKCNE1 currents (n ϭ 5) (Fig. 3A) . Thus, kinase (PKA) activity potently regulates I KS and inhibiting phosphatase (PP1) activity enhances this regulation.
Expression of yotiao was required to reconstitute cAMP-dependent regulation of the hKCNQ1-hKCNE1 channel in a heterologous expression system (CHO cells). In the absence of yotiao, there was no significant effect of intracellular cAMP (200 M) on hKCNQ1-hKCNE1 currents either in the absence or presence of OA (0.2 M n ϭ 5) (Fig. 3B) . With yotiao, hKCNQ1-hKCNE1 tail current (after ϩ60 mV conditioning pulses) was doubled by cAMP [without cAMP, 24.3 Ϯ 7.5 pA/pF; with cAMP (200 M), 50.7 Ϯ 9.2 pA/pF; n ϭ 5] and OA (0.2 M) plus cAMP (200 M) increased the hKCNQ1-hKCNE1 current ϳ4-fold (89 Ϯ 15.6 pA/pF, n ϭ 5) (Fig.  3B) .
Substituting Ala for Ser 27 (S27A) in KCNQ1, which is phosphorylated in response to cAMP, eliminated cAMP-dependent enhancement of hKCNQ1-hKCNE1 current (n ϭ 6, Fig. 3C ). Expression in CHO cells of hKCNE1 and yotiao with mutant hKCNQ1 (hKCNQ1-LZ m ) or the G589D mutant linked to LQTS (13), both of which disrupt the KCNQ1 LZ motif (Fig. 2D) , ab- lated cAMP-dependent regulation of I KS (n ϭ 5) (Fig. 3, D and E) . Thus, assembly of the macromolecular complex via LZ-mediated binding of yotiao to hKCNQ1, as well as PKA phosphorylation of Ser 27 , are necessary to reconstitute PKA-and PP1-dependent regulation of hKCNQ1-hKCNE1 channels.
The finding that the hKCNQ1-G589D mutation prevents cAMP-dependent regulation of I KS suggests that these mutant channels may not respond to ␤AR-mediated signaling in patients. Along with the reduced expression of I KS in carriers of the hKCNQ1-G589D mutation (13) , uncoupling of the channel from SNS modulation may exacerbate the defect in APD shortening and further increase the risk of exercise-induced ventricular tachyarrhythmias that cause sudden cardiac death (SCD) in some patients (6) . Indeed, SCD is associated with SNS stimulation in 81% of individuals with the KCNQ1-G589D mutation in whom a trigger event can be identified (13) , in contrast to other K ϩ channel mutations in which only ϳ10% of SCD cases are triggered by SNS activation (4) .
Taken together, our data show that the regulation of hKCNQ1 by PKA-dependent phosphorylation requires a macromolecular complex that includes PKA, PP1, and the targeting protein yotiao and provide a mechanistic link between the sympathetic nervous system and modulation of the cardiac APD through I KS . 22. Cardiac homogenates (500 g) were suspended in 0.5 ml of RIPA buffer and incubated with antibody to hKCNQ1 (Santa Cruz) for 2 hours at 4°C. Protein G-Sepharose beads were added, incubated at 4°C for 1 hour, washed with RIPA buffer, and resuspended in SDS sample buffer. Microcystin-sepharose (35 l; Upstate Biotechnology Inc.) and cAMP-Sepharose (40 l; Sigma) were incubated with cardiac membrane preparations (200 g) at 4°C for 1 hour and then washed. Samples were heated to 95°C and sizefractionated by SDS-polyacrylamide gel electrophoresis (PAGE), transferred to nitrocellulose membranes, immunoblotted with the primary antibody, and detected by enhanced chemiluminescence (ECL, Amersham). Primary antibodies: anti-PKA catalytic subunit (1:1000), anti-PP1 (1:1000) ( Transduction Laboratories, Lexington, KY ), anti-hKCNQ1 (1:1000) (Santa Cruz Biotechnology, Santa Cruz, CA), and antiyotiao [gift from M. Sheng (7) and from M. E. Gottesman (14)]. For preparation of CHO lysates, cells were washed twice 48 hours after transfection, scraped into phosphate-buffered saline, centrifuged at 4°C, and resuspended in 0.5 ml of 20 mM Hepes-NaOH ( pH 7.5) containing 1% Triton X-100 and EDTA-free protease inhibitors (Boehringer Mannheim). Lysates were centrifuged at 10,000g for 15 min, supernatants were collected, and protein concentration was determined by Bradford assay. 23. hKCNQ1-hKCNE1 (2.6 kb) cDNA (15) , the KCNQ1 LZ motif, and yotiao for PKA-dependent regulation of I KS . (A) Whole-cell patch clamp currents recorded from WT and TG ϩ (hKCNQ1-hKCNE1) murine cardiomyocytes (26) . Tail current after ϩ60 mV pulses was significantly increased by cAMP (P Ͻ 0.01, Student's t test, pre-cAMP versus cAMP, n ϭ 9) and by cAMP plus OA (P ϭ 0.01, Student's t test, pre-cAMP ϩ OA versus cAMP ϩ OA, n ϭ 5). Currents shown in upper traces were activated by a series of 2-s voltage pulses from -40 mV to ϩ80 mV (20-mV increments, 0.067 Hz) from a -65 mV holding potential and deactivated by returning to -40 mV. hKCNQ1-hKCNE1 channel current is evident as slowly activating outward current during pulses and deactivating current "tails" upon repolarization detectable in TG ϩ (arrow) but not TG -cells. Myocytes were treated with cAMP and OA (bottom two traces) and hKCNQ1-hKCNE1 currents were activated by depolarization (ϩ60 mV ). Currents recorded before (open circles) and after (solid circles) a 5-min external application of 8-Br-cAMP (300 M) or 8-Br-cAMP (300 M) plus OA (1.0 M). Scale: 20 pA/pF and 1 s. (B) Requirement of yotiao for cAMP and OA dependent modulation of hKCNQ1-hKCNE1 channels in CHO cells. Shown are mean currents (n ϭ 5) (ϩ60 mV pulse, -40 mV return) as well as plots of mean tail current Ϯ SEM vs. pulse voltage. Tail currents (after ϩ60 mV ) were significantly different by ANOVA P Ͻ 0.05. CHO cells were transfected with hKCNQ1-hKCNE1 without (left) or with (right) yotiao. Internal solutions without cAMP (control); with 200 M cAMP (cAMP); or with 200 M cAMP plus 0.2 M OA (cAMP/OA) were dialyzed at room temperature for 13 min before measurements were made. Open symbols, no yotiao; solid symbols, with yotiao. Squares, control; triangles, cAMP; circles, cAMP/OA. Scale: 100 pA/pF, 1 s. (C) Substituting Ala for Ser 27 in KCNQ1. I KS was measured in CHO cells cotransfected with yotiao, hKCNE1, and hKCNQ1-S27A (n ϭ 6). Scale: 100 pA/pF, 1 s. (D) Disruption of the KCNQ1 LZ motif by Ala substitution. CHO cells were transfected with yotiao, hKCNE1, and hKCNQ1-LZm (n ϭ 5). Scale: 100 pA/pF, 1 s. (E) Disruption of the KCNQ1 LZ motif with the LQTS mutation (G589D). CHO cells were transfected with yotiao, hKCNE1, and hKCNQ1-G589D (n ϭ 5). Scale: 50 pA/pF, 1 s. In (C) to (E), cells were dialyzed with cAMP/OA-containing (solid squares) or control (open squares) internal solutions. Currents and plots as in (B).
